{"abstract":"On March 1, 2023 the Drug Enforcement Administration (DEA), in concert with the Department of Health and Human Services (HHS), promulgated two notices of proposed rulemakings (NPRMs) soliciting comments on proposals to allow for prescribing of controlled medications pursuant to the practice of telemedicine in instances where the prescribing practitioner has never conducted an in-person medical evaluation of the patient. Those NPRMs resulted in 38,369 public comments, which are being closely reviewed. DEA, in concert with HHS, is considering revisions to the proposed rules set forth in the NPRMs. In the meantime, and following initial review of the comments received, DEA, jointly with the Substance Abuse and Mental Health Services Administration (SAMHSA), is issuing this temporary rule to extend certain exceptions granted to existing DEA regulations in March 2020 as a result of the COVID-19 Public Health Emergency (COVID-19 PHE), in order to avoid lapses in care for patients. Ultimately, there will be a final set of regulations permitting the practice of telemedicine under circumstances that are consistent with public health, safety, and effective controls against diversion.","action":"Temporary rule.","agencies":[{"raw_name":"DEPARTMENT OF JUSTICE","name":"Justice Department","id":268,"url":"https://www.federalregister.gov/agencies/justice-department","json_url":"https://www.federalregister.gov/api/v1/agencies/268","parent_id":null,"slug":"justice-department"},{"raw_name":"Drug Enforcement Administration","name":"Drug Enforcement Administration","id":116,"url":"https://www.federalregister.gov/agencies/drug-enforcement-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/116","parent_id":268,"slug":"drug-enforcement-administration"},{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2023/05/10/2023-09936.html","cfr_references":[{"chapter":null,"citation_url":null,"part":"1307","title":21},{"chapter":null,"citation_url":null,"part":"12","title":42}],"citation":"88 FR 30037","comment_url":null,"comments_close_on":null,"correction_of":null,"corrections":[],"dates":"This rule is effective May 11, 2023, through November 11, 2024.","disposition_notes":null,"docket_ids":["Docket No. DEA-407"],"dockets":[{"supporting_documents":[],"agency_name":"DEA","documents":[{"comment_count":0,"comment_start_date":"2023-05-10","updated_at":"2023-05-10T09:56:25.846-04:00","comment_url":"https://www.regulations.gov/commenton/DEA-2023-0029-35460","allow_late_comments":null,"id":"DEA-2023-0029-35460","comment_end_date":null,"regulations_dot_gov_open_for_comment":false}],"supporting_documents_count":0,"id":"DEA-2023-0029","title":"Telemedicine Prescribing of Controlled Substances (DEA407)"},{"supporting_documents":[],"agency_name":"HHS","documents":[{"comment_count":null,"comment_start_date":null,"updated_at":"2024-02-01T11:56:21.723-05:00","comment_url":"https://www.regulations.gov/commenton/HHS-OS-2024-0001-0008","allow_late_comments":null,"id":"HHS-OS-2024-0001-0008","comment_end_date":null,"regulations_dot_gov_open_for_comment":false}],"supporting_documents_count":0,"id":"HHS-OS-2024-0001","title":"HHS 2023 Archive"}],"document_number":"2023-09936","effective_on":"2023-05-11","end_page":30043,"executive_order_notes":null,"executive_order_number":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2023/05/10/2023-09936.xml","html_url":"https://www.federalregister.gov/documents/2023/05/10/2023-09936/temporary-extension-of-covid-19-telemedicine-flexibilities-for-prescription-of-controlled","images":{},"images_metadata":{},"json_url":"https://www.federalregister.gov/api/v1/documents/2023-09936?publication_date=2023-05-10","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2023-05-10/2023-09936/mods.xml","not_received_for_publication":null,"page_length":7,"page_views":{"count":32243,"last_updated":"2026-09-26 10:15:02 -0400"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2023-05-10/pdf/2023-09936.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2023-09936.pdf?1683636324","publication_date":"2023-05-10","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2023/05/10/2023-09936.txt","regulation_id_number_info":{"1117-AB40":{"issue":"202504","html_url":"https://www.federalregister.gov/regulations/1117-AB40/special-registrations-for-telemedicine-and-limited-state-telemedicine-registrations","title":"Special Registrations for Telemedicine and Limited State Telemedicine Registrations","xml_url":"http://www.reginfo.gov/public/do/eAgendaViewRule?pubId=202504&RIN=1117-AB40&operation=OPERATION_EXPORT_XML","priority_category":"Other Significant"},"1117-AB78":{"issue":"202504","html_url":"https://www.federalregister.gov/regulations/1117-AB78/expansion-of-induction-of-buprenorphine-via-telemedicine-encounter-","title":"Expansion of Induction of Buprenorphine via Telemedicine Encounter\n","xml_url":"http://www.reginfo.gov/public/do/eAgendaViewRule?pubId=202504&RIN=1117-AB78&operation=OPERATION_EXPORT_XML","priority_category":"Other Significant"}},"regulation_id_numbers":["1117-AB40","1117-AB78"],"regulations_dot_gov_info":{"supporting_documents":[],"comments_count":0,"agency_id":"HHS","comments_url":"https://www.regulations.gov/docketBrowser?rpp=50&so=DESC&sb=postedDate&po=0&dct=PS&D=HHS-OS-2024-0001","supporting_documents_count":0,"docket_id":"HHS-OS-2024-0001","document_id":"HHS-OS-2024-0001-0008","regulation_id_number":null,"title":"HHS 2023 Archive","checked_regulationsdotgov_at":"2024-02-02T15:00:13Z"},"regulations_dot_gov_url":null,"significant":true,"signing_date":null,"start_page":30037,"subtype":null,"title":"Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications","toc_doc":"Temporary Extension of COVID19 Telemedicine Flexibilities for Prescription of Controlled Medications","toc_subject":null,"topics":["Administrative practice and procedure","Drug traffic control","Prescription drugs"],"type":"Rule","volume":88}